A recent survey conducted by Abbott reveals that whilst progress has been made since COVID-19, significant gaps remain in global readiness for future disease outbreaks.
Advancements in glucose monitoring and insulin delivery systems are enabling people with type 1 diabetes to participate in demanding physical activities, while fear of hypoglycaemia remains a significant barrier to exercise for many.
Researchers at Karolinska Institutet have uncovered key neural processes behind morphine’s analgesic effects, potentially paving the way for safer pain management strategies.
Researchers at UCLA have identified common molecular markers in three major forms of dementia, offering new insights into neurodegeneration and potential therapeutic pathways.
In a significant move towards addressing the healthcare sector’s environmental impact, Joint Commission International (JCI) has announced the launch of its Healthcare Sustainability Certification (HSC) programme. Developed in collaboration with the International Hospital Federation’s Geneva Sustainability Centre (GSC), this new certification is set to become available from 1 January 2025 for healthcare organisations outside the […]
The annual gathering brings together over 1,250 delegates from 65 countries to address pressing challenges in hospital management and healthcare delivery.
Researchers at The Rockefeller University have identified a rare genetic mutation that increases vulnerability to tuberculosis, potentially reshaping our understanding of tumour necrosis factor’s role in the immune system.
Researchers have developed a novel method to make skin and underlying tissues transparent using a common food dye, heralding potentially far-reaching applications for a wide range of medical diagnostics and certain treatments.
A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.
New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
